Since epilepsy is the thing that I have been writing about this semester, I figure I will stick with it. I know I have already addressed some of the adverse effects of the medications used to treat the disorder, but now I am going to delve deeper into the side effects poly (multiple) therapy versus momo (single) therapy. Specifically, how they differ in the side effects. For example, often times the more medications a person takes the greater number or more severe side effects.
Witt, Elger, and Helmstaedter (2015) conducted a retrospective study on the effects of the number of medications patients take as treatment. The cognitive assessment used by all of the studies that they looked at used EpiTrack, which “assesses response inhibition, visuo-motor speed, mental flexibility, visual motor planning, verbal fluency and working memory” (p. 1955). Through the assessment of the data collected from the other studies, it was determined that the number of medication a person takes does tend to increase side effects. The dosage of the medications also have an impact.
My experience with this just happens to be with verbal fluency. As I may have mentioned earlier, I have issues with keeping what I want to type in my mind long enough for me to type it. I also have a great amount of difficulty conversing with people. In my opinion, it is the most frustrating side effect that I have experienced thus far. Actually, just today I told my husband something that he told me that I had already told him yesterday! As Witt, Elger, and Helmstaedter (2015) state, “With regard to the cognitive side effects of antiepileptic pharmacotherapy, the presented data indicate that each additional drug matters” (p. 1959). If I failed to mention this earlier this semester, I am currently on four antiepileptic medications. On a final note, one of the medications was just recently increased, so I am still adjusting to it. I am just hoping I can tolerate it.
References:
Witt, J., Elger, C. E., & Helmstaedter, C. (2015). Adverse effects of antiepileptic pharmacotherapy: Each additional drug matters. European Neuropsychopharmacology, 25, 1954-1959.